statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

iTeos Therapeutics presents preclinical data on EOS-984

WATERTOWN, Mass. and GOSSELIES, Belgium, April 07, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and...

iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024

This is a signal that ITOS's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

iTeos Therapeutics (ITOS, $13.35) RSI Indicator left the overbought zone on April 01, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS - Get Free Report) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 2,010,000 shares, an...

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Sees Significant Increase in Short Interest

iTeos Therapeutics (ITOS, $13.19) RSI Indicator left the overbought zone on March 27, 2024

This indicator may be signaling that ITOS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

iTeos Therapeutics (ITOS, $10.81) entered Downtrend as Momentum indicator drops below 0 level on Mar 15, 2024

iTeos Therapeutics management to meet with Piper Sandler

iTeos Therapeutics (ITOS, $11.93) RSI Indicator left the overbought zone on March 11, 2024

Trexquant Investment LP grew its position in shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS  Free Report) by 10.8% during the 3rd quarter, according to the company in its most recent filing...

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Bought by Trexquant Investment LP

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on iTeos Therapeutics (ITOS Research Report), Viracta Therapeutics...

Analysts Are Bullish on These Healthcare Stocks: iTeos Therapeutics (ITOS), Viracta Therapeutics (VIRX)

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.

Watchers	396
52-Wk Low	$8.20
52-Wk High	$18.24

Volume	84,546.00
52-Wk High	$18.24
52-Wk Low	$8.20

ITOS ITeos Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals